Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-26

Clinical Trial Update: Glenohumeral Cortisone Injection [Phase 2]

View source ↗

Summary

Phase 2 trial update on glenohumeral cortisone injection for humeral fractures has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glenohumeral cortisone injection

Snippet

Sponsor: University of Washington | Conditions: Humeral Fractures | Phase 2 | Status: COMPLETED | Results posted: 2023-09-26